Source: Eur Respir J, 50 (5) 1701153; 10.1183/13993003.01153-2017
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Cindy A. Verberkt, Marieke H.J. van den Beuken-van Everdingen, Jos M.G.A. Schols, Sushma Datla, Carmen D. Dirksen, Miriam J. Johnson, Sander M.J. van Kuijk, Emiel F.M. Wouters, Daisy J.A. Janssen. Respiratory adverse effects of opioids for breathlessness: a systematic review and meta-analysis. Eur Respir J, 50 (5) 1701153; 10.1183/13993003.01153-2017

Member's Comments

No comment yet.

Related content which might interest you: Respiratory disturbances in fibromyalgia: A systematic review and meta-analysis of case control studies Source: Virtual Congress 2021 – What's new in respiratory problems in rare and systemic diseases Year: 2021 Adverse events and cardiovasular effects of vilanterol in paediatric asthma: a systematic review Source: International Congress 2019 – Severe acute asthma and troublesome wheezing Year: 2019 Association between COPD exacerbations and acute cardiovascular events: a systematic literature review Source: Virtual Congress 2021 – Treatments for airway diseases Year: 2021 Adverse childhood experience and asthma onset: a systematic review Source: Eur Respir Rev 2015; 24: 299-305 Year: 2015 The effects of pharmacological interventions on quality of life and fatigue in sarcoidosis: a systematic review Source: Eur Respir Rev, 29 (155) 190057; 10.1183/16000617.0057-2019 Year: 2020 Pharmacists and medication adherence in asthma: a systematic review and meta-analysis Source: Eur Respir J, 52 (2) 1800485; 10.1183/13993003.00485-2018 Year: 2018 Efficacy of psychosocial intervention in COPD: a systematic review and meta-analysis Source: Virtual Congress 2020 – Optimising the benefits of pulmonary rehabilitation Year: 2020 Risk of mortality associated with formoterol: a systematic review and meta-analysis Source: Eur Respir J 2009; 34: 803-811 Year: 2009 Blood eosinophilia as predictor for outcomes in COPD exacerbations: a systematic review and meta-analysis Source: International Congress 2017 – Management of COPD Year: 2017 Does the use of inhaled corticosteroids in asthma benefit lung function in the long-term? A systematic review and meta-analysis Source: Eur Respir Rev, 30 (159) 200185; 10.1183/16000617.0185-2020 Year: 2021 The association between adherence and outcomes in severe asthma: a systematic review Source: International Congress 2019 – Long-term evaluation and control of airway diseases Year: 2019 Inhaled corticosteroids in asthma and longitudinal change in lung function: a systematic review and meta-analysis Source: International Congress 2019 – Asthma treatment: cohorts and real-world studies Year: 2019 Medication adherence and the risk of severe asthma exacerbations: a systematic review Source: Eur Respir J 2015; 45: 396-407 Year: 2015 Investigating asthma comorbidities: a systematic scoping review Source: International Congress 2017 – Many faces of asthma and allergies Year: 2017 The global epidemiology of chronic cough in adults: a systematic review and meta-analysis Source: Eur Respir J 2015; 45: 1479-1481 Year: 2015 A systematic review of nursing interventions for breathlessness in COPD Source: International Congress 2017 – Patient experience of smoking cessation: new approaches Year: 2017 The effects of nebulised beta-2 agonists on clinical observations in asthma exacerbations: a systematic review Source: Virtual Congress 2021 – Advances in asthma treatment Year: 2021 Prevalence of nonadherence to controller therapy in adults with severe asthma – a systematic review and meta-analysis Source: International Congress 2019 – Long-term evaluation and control of airway diseases Year: 2019 Evaluating inhaled corticosteroid use among pregnant women with asthma: systematic review and meta-analysis Source: International Congress 2019 – Asthma treatment: cohorts and real-world studies Year: 2019 Glaucoma risk due to antimuscarinics, not a class effect: A systematic review Source: International Congress 2016 – Novel avenues in the treatment of COPD II Year: 2016